Theseus Pharmaceuticals Inc (OQ:THRX)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for THRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 30th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 15/21 Oct 15/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Series A Preferred Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/21 Oct 12/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Series A Preferred Stock C - Conversion -1,615,427  
Oct 15/21 Oct 12/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Common Stock C - Conversion 1,615,427  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series B Convertible Preferred Stock C - Conversion -436,650  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series B Convertible Preferred Stock C - Conversion -873,300  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series A Convertible Preferred Stock C - Conversion -14,903,718  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock P - Open market or private purchase 62,500 $16.00
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock P - Open market or private purchase 562,500 $16.00
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock C - Conversion 436,650  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock C - Conversion 15,777,018  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for THRX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET November 30th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 15/21 Oct 12/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Series A Preferred Stock C - Conversion -1,615,427  
Oct 15/21 Oct 12/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Common Stock C - Conversion 1,615,427  
Oct 15/21 Oct 15/21 Takeda Pharmaceutical Co Ltd Indirect Ownership Series A Preferred Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series B Convertible Preferred Stock C - Conversion -436,650  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series B Convertible Preferred Stock C - Conversion -873,300  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Series A Convertible Preferred Stock C - Conversion -14,903,718  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock P - Open market or private purchase 62,500 $16.00
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock P - Open market or private purchase 562,500 $16.00
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock C - Conversion 436,650  
Oct 14/21 Oct 12/21 Gordon Carl L Indirect Ownership Common Stock C - Conversion 15,777,018  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $THRX

Competitors

Competitors with Recent Insider Filings
Regeneron Pharmaceuticals (OQ:REGN)
Arvinas (OQ:ARVN)
Dynavax Technologies (OQ:DVAX)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.